Who has invested in NewLeaf Symbiotics?

Koch Agronomic Holdings, Leaps by Bayer, Otter Capital, S2G Ventures, RockPort Capital are named among the investors backing NewLeaf Symbiotics.

NewLeaf Symbiotics Funding: $122M Raised, Series D (2023)

NewLeaf Symbiotics funding overview

NewLeaf Symbiotics is a Biotech company based in St. Louis, Missouri. NewLeaf Symbiotics has raised $122M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series D announced in December 2023. The round record for NewLeaf Symbiotics runs through 2023; nothing later has been disclosed. Investors on record include Koch Agronomic Holdings, Leaps by Bayer, Otter Capital, S2G Ventures, RockPort Capital. 5 distinct backers are named across the disclosed rounds.

NewLeaf Symbiotics at a glance

Total raised: $122M
Latest round: Series D
Latest round date: December 2023
Industry: Biotech
Headquarters: St. Louis, Missouri
Notable investors: Koch Agronomic Holdings, Leaps by Bayer, Otter Capital, S2G Ventures, RockPort Capital

Frequently asked about NewLeaf Symbiotics funding

How much has NewLeaf Symbiotics raised?: NewLeaf Symbiotics has raised $122M in total disclosed funding across the rounds on record.
Who has invested in NewLeaf Symbiotics?: Koch Agronomic Holdings, Leaps by Bayer, Otter Capital, S2G Ventures, RockPort Capital are named among the investors backing NewLeaf Symbiotics.
What was the latest NewLeaf Symbiotics funding round?: The most recent disclosed round is a Series D, announced in December 2023.
Where is NewLeaf Symbiotics based?: NewLeaf Symbiotics is based in St. Louis, Missouri.
What sector does NewLeaf Symbiotics operate in?: NewLeaf Symbiotics is tracked under Biotech from St. Louis, Missouri, with $122M in disclosed funding.
When did NewLeaf Symbiotics last raise?: The last disclosed NewLeaf Symbiotics round closed in December 2023 at Series D.

NewLeaf Symbiotics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in St. Louis below to benchmark round size and investor mix.

NewLeaf Symbiotics Funding: $122M Raised, Series D (2023)

NewLeaf Symbiotics funding overview

NewLeaf Symbiotics at a glance

Frequently asked about NewLeaf Symbiotics funding

Companies related to NewLeaf Symbiotics (38)

Browse related funding lists (5)